Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Multiple Myeloma Patient Registry - Prospective National Multi Center Prospective Study

NCT04143932 is registered in ClinicalTrials.gov with Turkish Hematology Association as lead sponsor.

NCT NCT04143932
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04143932 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Multiple Myeloma Patient Registry - Prospective National Multi Center Prospective Study
Lead sponsor
Turkish Hematology Association
Phase
Observational
Overall status
Unknown status
Start date
October 10, 2020
Completion date
December 31, 2024
Enrollment
1,000 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

multiple myeloma, relapse multiple myeloma